D. Scott Bowden

Medicine · Health Sciences

33h-index3.4kcitations102works0.52yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(55), Hepatitis B Virus Studies(46), Liver Disease Diagnosis and Treatment(25), Hepatitis Viruses Studies and Epidemiology(13), Virology and Viral Diseases(10)

Publications102 total

Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
La Trobe University·2026Open Access
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
La Trobe University·2026Open Access
Integrating Presence‐Only Data Into Spatio‐Temporal Models to Support Fisheries Assessments and Management in Freshwater and Marine Environments
Fish and Fisheries·2025· 2 cited
Early Signs of Recovery Suggested by Changes in the Structure and Function of Deep-Sea Megabenthic Communities on a Seamount 19 Years after Fishing
SSRN Electronic Journal·2024Open Access
Semantic Programming for Device-Edge-Cloud Continuum
2023Open Access
Semantic Programming for Device-Edge-Cloud Continuum
arXiv (Cornell University)·2023Open Access
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants
Hepatology Communications·2023· 15 citedOpen Access
Network Programmability for Smart Factory Mobile Robotics: the SmartEdge Project Approach
2023· 1 citedOpen Access
Supplementary material to "An atlas of seabed biodiversity for Aotearoa New Zealand"
2023
Impact of COVID-19 on CT imaging in a tertiary care hospital
Clinical Radiology·2022Open Access
An atlas of seabed biodiversity for Aotearoa New Zealand
2022Open Access
An atlas of seabed biodiversity for Aotearoa New Zealand
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Stopping nucleot(s)ide analogues in non‐cirrhotic <scp>HBeAg</scp>‐negative chronic hepatitis B patients: <scp>HBsAg</scp> loss at 96 weeks is associated with low baseline <scp>HBsAg</scp> levels
Alimentary Pharmacology & Therapeutics·2022· 33 cited
SemRob: Towards Semantic Stream Reasoning for Robotic Operating Systems
arXiv (Cornell University)·2022Open Access
&lt; QC | HPC &gt;: Quantum for HPC
Zenodo (CERN European Organization for Nuclear Research)·2021· 1 citedOpen Access
The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research—Lessons in Scientific Community Outreach
Viruses·2021Open Access
Biochemical characterization of rubella virus
Figshare·2021Open Access
The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs
Epidemiology and Infection·2016· 30 citedOpen Access
Vidal <scp>LL</scp>, et al. <scp>NS</scp>3 protease polymorphisms and genetic barrier to drug resistance of distinct <scp>HCV</scp> genotypes from worldwide treatment‐naive subjects. <scp>JVH</scp>, 2016, 23(11): 840‐849
Journal of Viral Hepatitis·2016· 2 citedOpen Access
Statistical Evaluation of Diagnostic Tests
2016
page 1 of 6Next →

Frequent Co-authors

Stephen Locarnini(14), Stuart K. Roberts(7), Mark D. Berzsenyi(7), Lee Jy(6), Samantha Tracy(6), Campbell Aitken(6), Rhonda McCaw(6), Margaret Hellard(5), Len D Moaven(5), Peter Revill(5), Alan Breschkin(4), Mandvi Bharadwaj(4), E. G. Westaway(4), Kumar Visvanathan(4), Alexander Thompson(4), Paul Desmond(4), Christopher J. Birch(3), John Marshall(3), F. J. Dudley(3), Peter Angus(3)